Welcome to LookChem.com Sign In|Join Free

CAS

  • or

676133-21-4

Post Buying Request

676133-21-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

676133-21-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 676133-21-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,1,3 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 676133-21:
(8*6)+(7*7)+(6*6)+(5*1)+(4*3)+(3*3)+(2*2)+(1*1)=164
164 % 10 = 4
So 676133-21-4 is a valid CAS Registry Number.

676133-21-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Naphthalenol,7-ethyl-1,2,3,4-tetrahydro-,(1R)-(9CI)

1.2 Other means of identification

Product number -
Other names 7-ethyl-1-naphthoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:676133-21-4 SDS

676133-21-4Upstream product

676133-21-4Downstream Products

676133-21-4Relevant articles and documents

2-AMINO- AND 2-THIO-SUBSTITUTED 1,3-DIAMINOPROPANES

-

Page/Page column 111-112, (2008/06/13)

Disclosed are compounds of the formula: where variables Q, Z, X, R15, R2, R3, and Rc are defined herein. Compounds disclosed herein are inhibitors of the beta-secretase enzyme and are therefore useful in the treatment of Alzheimer’s disease and other diseases characterized by deposition of A beta peptide in a mammal.

BENZAMIDE 2-HYDROXY-3-DIAMINOALKANES

-

Page 64-65, (2010/02/09)

The present invention relates to compounds of formula (I) useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are also useful in pharmaceutical compositions and methods of treatment to reduce A beta peptide formation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 676133-21-4